Hopital Albert Calmette - CHU Lille

Lille, Nord 59037

1 studies enrolling now · 2 studies all time

What they study most

Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, NSCLC, NSCLC (Advanced Non-small Cell Lung Cancer), NSCLC (Non-small Cell Lung Cancer), NSCLC (Non-small Cell Lung Carcinoma), Non-Small Cell Lung Cancer

Studies at this site

• Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301) — Recruiting now
• Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION) — Running, not enrolling